Back to the feed
Disclosure detail

Basilea Pharmaceutica AG, Allschwil

21.08.2026 · T1Q8L000B4

In brief

On 21.08.2026, a person holding the function "Non-executive member of the board of directors" at Basilea Pharmaceutica AG, Allschwil disclosed a sale worth CHF 54’621 to SIX Exchange Regulation.

By amount, this ranks #9 of 18 management sales disclosed at Basilea Pharmaceutica AG, Allschwil over the previous 12 months.

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Disclosure detail

A non-executive member of the board of directors of Basilea Pharmaceutica AG, Allschwil declared a "Sale" transaction on 21.08.2026.

SIX publishes the manager's function, never their name: no individual is named in management transactions.

Transaction date21.08.2026
Issuing companyBasilea Pharmaceutica AG, Allschwil
ISINCH0011432447
Transaction sideSale
Management functionNon-executive member of the board of directors
Security typeRegistered shares
Quantity854
Unit priceCHF 63.96
AmountCHF 54’621
ExchangeXSWX
Notification IDT1Q8L000B4

Other Basilea Pharmaceutica AG, Allschwil insider transactions

These figures aggregate public disclosures. They are not investment advice.